News

View our latest research stories.

September 20, 2024 Profile Feature

Off-hours with Andria Eisman, a Clinical Practitioner-turned Implementation Science Researcher

CHERISH Research Affiliate Andria (Andi) Eisman first connected with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) over a site visit to New York City. At the time, she was a 2021 Implementation Research Institute (IRI) Fellow at the Brown School of Social Work at Washington University […]

September 12, 2024 Research Highlights

Insurance Instability for Patients with Opioid Use Disorder in the Year After Diagnosis

Access to health insurance is crucial to gaining the necessary diagnostic and therapeutic services to achieve and maintain good health. Insurance is especially necessary to access medications for opioid use disorder (MOUD) as the cost of MOUD can be a barrier to staying in treatment. If insurance coverage is disrupted, MOUD treatment may be more […]

noah jenkins is pictured on the left and simrun rao is pictured on the right
August 19, 2024 Profile Feature

Intern Spotlight: Noah Jenkins and Simrun Rao

At the start of summer, we welcomed undergraduate students Noah Jenkins and Simrun Rao. As rising seniors, Jenkins and Rao have been selected as part of the Summer Undergraduate Mentored Research (SUMR) Program at University of Pennsylvania and the NIDA Summer Research Internship Program. Working alongside CHERISH investigators Zachary Meisel at the Leonard Davis Institute […]

August 12, 2024 Research Highlights

Association between claims-based setting of diagnosis and treatment initiation among Medicare patients with Hepatitis C

Direct-acting antivirals (DAAs) have been available since 2015 for hepatitis C (HCV). Nonetheless, very few patients with HCV initiate DAA treatment, ranging from 5% to 30%. The location where a patient is first diagnosed can also influence the care patients receive afterward, especially when a referral to a specialist or coordinated care is needed. In […]

Sabrina Assoumou poses in front of and points to the billboard that talks about staying up to date with covid and flu vaccines.
June 14, 2024 Profile Feature

Off-hours with Sabrina A. Assoumou, an Infectious Diseases Clinician-investigator and Boston Runner

In recent years, CHERISH Research Affiliate Sabrina A. Assoumou has become a familiar face in Boston and a trusted voice in the scientific community. An infectious diseases physician and clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine and the Center for Infectious Diseases at Boston Medical Center, Assoumou appeared in local and […]

Collaged image of a portrait of Ali Jalali, oral medication, and two individuals collaborating.
June 13, 2024 Research Highlights

Informing Evidence-Based Medicine for Opioid Use Disorder Using Pharmacoeconomic Studies

Since 2021, over 100,000 individuals have died each year from a drug overdose, with approximately 76 percent of those deaths involving opioids.  As the US health care system contends with this growing health crisis, improved access to evidence-based medication treatment for opioid use disorder (OUD) is imperative. Pharmacoeconomics, a branch of health economics used to evaluate comparative clinical, person-centered, and economic outcomes […]

May 2, 2024 Research Highlights

Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus

Children with perinatally acquired hepatitis C virus (HCV) are now eligible to receive direct-acting antivirals (DAAs), a highly effective treatment for HCV, as early as the age of 3. Despite existing studies demonstrating DAA’s high efficacy and tolerance among adults and children between the 3 and 12 years old, there has been low uptake due […]

April 17, 2024 Research Highlights

7 Ways to Improve an Already Effective Treatment for Stimulant Use Disorder

The opioid epidemic has been one of the most pressing and challenging issues that the U.S. has faced in recent decades, with countless lives lost to this devastating crisis. Now, stimulant-related overdoses are among the next big drug-related concerns, with recent studies showing that the mortality rate linked to stimulant use in the U.S. has […]

April 8, 2024 Research Highlights

Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review

In this systematic literature review published in Value in Health, CHERISH Research Affiliates Czarina Behrends and Ahmed Bayoumi, CHERISH staff members Jared Leff, Jazmine Li, and Erminia Fardone, CHERISH investigators Kathryn McCollister, Sean M. Murphy, and Bruce Schackman, and former NIDA summer intern, Weston Lowry, analyzed 16 studies that summarized and identified gaps of economic […]

a lit candle is seen against a dark background
April 2, 2024 Research Highlights

New Study Reveals Preventable-Suicide Risk Profiles

Individuals with physical health concerns made up the largest and fastest growing of five subgroups of individuals who died by suicide n the United States over roughly twenty years, according to an analysis led by Weill Cornell Medicine in collaboration with Columbia University, UC Berkeley School of Public Health, the University of Hong Kong and […]

March 8, 2024 Research Highlights

Surgeons Are Closer to Predicting Which Patients Need Post-Surgery Opioids—and Which Ones Don’t

Opioids are routinely prescribed to patients after a surgery—whether they use them or not. A new study, led by LDI Senior Fellow Anish Agarwal will help tailor prescribing so patients get the right amount of opioid medications; not too little and not too much. Unused opioids are a particular problem. Opioid misuse can start when extra tablets […]

March 8, 2024 Research Highlights

Chart of the Day: Rise in Patients with Opioid Use Disorder Leaving Hospital Prematurely

LDI Senior and Associate Fellows Ashish Thakrar, Margaret (Maggie) Lowenstein, Ryan Greysen, and M. Kit Delgado found that more people with opioid use disorder are leaving the hospital prematurely (or before medically advised), compared to marginal increases for individuals admitted for other reasons. In the study, “Trends in Before Medically Advised Discharges for Patients with Opioid Use Disorder, 2016-2020,” […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.